Xarelto User Faces Hard Sell In 1st Philly Mass Tort Trial
As the first Philadelphia trial over alleged injuries from the blood-thinner Xarelto prepares to open on Monday, attorneys say defense verdicts notched by Johnson & Johnson and Bayer AG in three...To view the full article, register now.
Already a subscriber? Click here to view full article